SEC Form 4 · accession 0000899243-15-004949
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Fortune
Officer — Chief Operating Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 15, 2015 | S | 9,470 | $17.16 | D | 112,060 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.49, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2Includes 394 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan ("ESPP") on December 31, 2014 and 1,629 shares acquired under the ESPP on June 30, 2015.